Showing results (321-330 of 918) with videos related to
Sort By:
Pageof 92
Seminars in Liver Disease|December 23, 2011
HCV and HCC: clinical update and a review of HCC-associated viral mutations in the core geneJawad Ahmad, Francis J Eng, Andrea D BranchNMR in Biomedicine|August 1, 1990
Renal distribution and metabolism of [2H9]choline. A 2H NMR and MRI studyJ Eng, B A Berkowitz, R S BalabanJournal of Neuroengineering and Rehabilitation|October 15, 2015
Gait speed using powered robotic exoskeletons after spinal cord injury: a systematic review and correlational studyDennis R Louie, Janice J Eng, Tania Lam, et al.Biophysical Journal|November 1, 2005
Kinetic analysis of the metal binding mechanism of Escherichia coli manganese superoxide dismutaseMei M Whittaker, Kazunori Mizuno, Hans Peter Bächinger, et al.Human Heredity|January 1, 1988
Family studies of the E1kE1s genotype for plasma cholinesteraseM Whittaker, J J Britten, A B Vyas, et al.The Journal of Biological Chemistry|April 15, 2004
Calorimetric studies on the tight binding metal interactions of Escherichia coli manganese superoxide dismutaseKazunori Mizuno, Mei M Whittaker, Hans Peter Bächinger, et al.The British Journal of Surgery|December 1, 1994
Amelioration of experimental acute pancreatitis with a potent platelet-activating factor antagonistL J Formela, L M Wood, M Whittaker, et al.Climacteric : the Journal of the International Menopause Society|June 3, 2014
Women's expectations and experiences of hormone treatment for sexual dysfunctionE Fooladi, R J Bell, A M Whittaker, et al.Biochemistry|October 25, 1994
Structural characterization of the copper site in galactose oxidase using X-ray absorption spectroscopyK Clark, J E Penner-Hahn, M Whittaker, et al.British Journal of Pharmacology|August 22, 2006
Nupafant, a PAF-antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation?K E Baker, L M Wood, M Whittaker, et al.Pageof 92